News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Stephen V Liu Shared NEOADAURA Results Published in JCO After ASCO25 Presentation
Stephen V Liu/X
Jun 8, 2025, 06:08

Stephen V Liu Shared NEOADAURA Results Published in JCO After ASCO25 Presentation

Stephen V Liu, Associate Professor of Medicine at Georgetown University, shared a post on X:

“NEOADAURA results published in JCO after ASCO 2025 presentation.
In patients with resectable EGFR-Mutated NSCLC, neoadjuvant osimertinib for 9 weeks led to MPR rate of 25%, osimertinib + chemotherapy MPR 26%, and placebo + chemotherapy MPR of 2%. EFS rates high, but most patients received adjuvant osimertinib.”

Title: Neoadjuvant Osimertinib for Resectable EGFR-Mutated Non-Small-Cell Lung Cancer

Journal: Journal of Clinical Oncology

Authors: Jianxing He, Masahiro Tsuboi, Walter Weder, Ke-Neng Chen, Maximilian J. Hochmair, Jin-Yuan Shih, Sung Yong Lee, Kang-Yun Lee, Nguyen Viet Nhung, Somcharoen Saeteng, Lunxu Liu, Ligang Xing, Nguyen Hoang Gia, Shuji Murakami, Yongtao Han, María Paz Saavedra, Seong Hoon Yoon, Carlos H.A. Teixeira, Carles Escriu, Alex Martinez-Marti, Collin M. Blakely, Yasushi Yatabe, Sanja Dacic, Yuri Rukazenkov, Xiangning Huang, Anupriya Dayal, Jamie E. Chaft

Read the full abstract.

NEOADAURA

More posts featuring Stephen V Liu on OncoDaily.

Alex Martínez-Martí Anupriya Dayal ASCO ASCO 2025 ASCO25 cancer Carles Escriu Carlos H.A. Teixeira Collin M. Blakely EGFR-mutant NSCLC Georgetown University Jamie E Chaft JCO Jianxing He Jin-Yuan Shih Kang-Yun Lee Ke-Neng Chen Ligang Xing Lunxu Liu María Paz Saavedra Masahiro Tsuboi Maximilian J. Hochmair NeoADAURA Nguyen Hoang Gia Nguyen Viet Nhung OncoDaily Oncology Sanja Dacic Seong Hoon Yoon Shuji Murakami Somcharoen Saeteng Stephen V Liu Sung Yong Lee Walter Weder Xiangning Huang Yasushi Yatabe Yongtao Han Yuri Rukazenkov
Special Coverage
Blog
Jul 20, 2025, 00:12
Honoring Nelson Mandela International Day - ACREOL Global
Career
Jul 19, 2025, 21:24
2 Exciting Career Opportunities in Nanomedicine - European Technology Platform on Nanomedicine
Blog
Jul 19, 2025, 21:24
Mission to Educate Young People About Early Detection and Cancer Prevention - Pink Africa Foundation
Opinion
Jul 19, 2025, 21:11
Toufic Kachaamy: An Industry Insider’s Perspective on the Future of AI in GI
Blog
Jul 19, 2025, 21:06
Hossam Abdulkhalek: Understanding Outcomes for Cancer Patients Receiving Systemic Therapy ePoster at ESMO 2025
Positive
Jul 19, 2025, 20:58
World Child Cancer Stood Behind 5391 Families in 2024
Blog
Jul 19, 2025, 20:55
Susanna Fletcher Greer: New Hope Emerges for Children Battling Devastating Brain Cancer
Blog
Jul 19, 2025, 20:47
Joachim Schüz: Strong Science Behind Environment and Health - Look Inside the 40th Conference
Blog
Jul 19, 2025, 20:26
Why St. Jude Children's Research Hospital - ALSAC Leads Childhood Cancer Care
Blog
Jul 19, 2025, 20:21
Impressed by How They Translate Ground-Breaking Research to Patient Care
Career
Jul 19, 2025, 20:17
Elizabeth Cathcart-Rake Is the recipient of the 2025 Outstanding Publication Award - MASCC
Blog
Jul 19, 2025, 20:15
The Official Launch Ceremony of ELLOK as the Greek Cancer Mission Hub - The Hellenic Cancer Federation